TRPC6 and breast carcinoma: Interestingly, while ppFurin expression in MDA-MB-231, BT20, and MDA-MB-435 cells repressed their ability to migrate or invade, ppFurin affected viability only in the two breast cancer cell lines where Orai and TRPC6 hyperactivation was observed.